CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 4,573 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 4,574 shares (option exercise)
- 4 Open-market buy Director bought 1,860 shares at $5.34 ($9,924)
- 4 Open-market buy 10% owner bought 1,000,000 shares at $4.03 ($4,030,000)
- 4 Open-market buy Director bought 5,000,000 shares at $4.03 ($20,150,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 252,545 shares at $7.56 ($1,909,240)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Regulatory Officer sold 3,079 shares at $3.96 ($12,193)
- 4 Planned sale Chief Medical Officer sold 3,256 shares at $3.96 ($12,894)
Page 4 of 20 · 383 filings